Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede
← Scopes/
HIV/AIDS SurveillanceHealth
  • Overview
  • Synthesis
  • Assessments
  • Evidence

Public note

For situational awareness and research transparency. Not medical advice.

Synthesis · HIV/AIDS Surveillance

All HIV/AIDS connectors stale from Apr 21 timeouts; zero HIV-specific evidence this cycle; hypotheses unchanged at prior confidence levels.

Emergence-focused surveillance for HIV transmission clusters, transmitted drug resistance, recombinant forms, and treatment failure signals

Updated Apr 22, 2026

Synthesis

DepthL3
L1

Key findings

All primary connectors failed on Apr 21 (Africa CDC, CDC MMWR, ProMED timeout; PAHO, WHO DON no-items or error), leaving this scope with no new HIV-relevant evidence for this cycle. The six active hypotheses — led by PEPFAR impoundment court ruling (conf 8) and viral-load testing decline (conf 7) — maintain prior confidence levels. Penobscot County Maine PWID-driven outbreak and PEPFAR cascade disruption signals remain the primary watch items. Calibration accuracy is 0.0 for both mid and high confidence buckets across 5 resolved hypotheses, warranting downward pressure on confidence assignments.

L2

Technical analysis

No HIV-specific evidence was ingested this cycle. The only items returned by research_query were ProMED foodborne illness Vietnam posts (misclassified) and the prior synthesis page. This represents the second consecutive cycle with near-zero HIV-specific evidence, driven by a systematic connector failure pattern across all major feeds on Apr 21.

PubMed ok ratio is 8.8% (57 runs, 5 ok). ProMED timed out on Apr 21. Africa CDC timed out. CDC MMWR timed out. PAHO timed out. WHO DON returned no items. GISAID and genomic-surveillance are inactive. All 9 connectors are either stale or inactive.

Calibration signal is concerning. With 5 resolved hypotheses and 0.0 accuracy in both the 4-6 (mid) and 7-10 (high) confidence buckets, the analyst generating HIV/AIDS hypotheses is systematically overconfident. Future hypotheses in this scope should carry confidence scores 1-2 points below initial instinct.

L3

Full appendix

PEPFAR court ruling (hyp:hiv-aids:p180d:e0d066a05e, conf 8): Multiple impoundment suits were pending as of Apr 18. No new court ruling has entered the evidence stream. This remains the highest-confidence hypothesis and is the most likely to resolve in the next 90 days given active litigation. Legal database feeds (not currently connected) would be the most direct resolution path.

VL testing decline ≥20% (hyp:hiv-aids:p180d:022fb033cf, conf 7): PEPFAR funding disruption logic holds; no country-specific reporting data visible in this cycle.

EECA rising incidence ≥15% YoY (hyp:hiv-aids:p180d:c3129cb218, conf 6): No UNAIDS or national surveillance data this cycle.

MTCT ≥10% increase (hyp:hiv-aids:p180d:04eed04800, conf 6): No PMTCT cascade data from PEPFAR-supported countries. PAHO maternal health items (Apr 19) captured in scope but not PMTCT-specific.

Penobscot County ≥75 cases (hyp:hiv-aids:p90d:bd131411de, conf 6): 40 confirmed cases as of Mar 20 2026; outbreak still growing as of Apr 7. No CDC or Maine DHHS update in evidence stream. Resolves Jul 17.

Lenacapavir breakthrough (hyp:hiv-aids:p180d:d83754cd2a, conf 4): No case report in peer-reviewed literature or pharmacovigilance. Rollout in Zambia/Zimbabwe ongoing.

Operational priority: Connector health must be addressed — 0/9 connectors delivering data today is a structural failure, not a quiet-news-day artifact.

02

Scope signals

Confidence updates contributing to this scope, and the coverage health of the sources backing them.

Confidence updates

HypothesisPriorDirectionMagnitudeReasoning
At least one PEPFAR-dependent sub-Saharan African country will report a ≥20% absolute decline in HIV viral-load testing volume in 2025 vs 2024, published in PEPFAR Country Operational Plan data, WHO HIV reports, peer-reviewed literature, or official MoH statistics within 180 days.7neutral0.0No new data; connector drought
At least one Eastern Europe / Central Asia (EECA) country will release official national HIV surveillance data showing a ≥15% year-over-year increase in newly diagnosed HIV cases (2024 vs 2023 OR 2025 vs 2024), published in UNAIDS, ECDC, WHO EURO, or national MoH surveillance reports within 180 days.6neutral0.0No new data; connector drought
At least one PEPFAR-supported sub-Saharan African country will report a ≥10% relative increase in mother-to-child HIV transmission rate in a 2025 cohort vs 2024 baseline, published in PEPFAR Country Operational Plan data, UNICEF Global AIDS Update, UNAIDS epidemiological estimates, or peer-reviewed literature within 180 days.6neutral0.0No new data; connector drought
A US federal court (district, appellate, or Supreme Court) will issue at least one substantive ruling (merits opinion, preliminary injunction, or contempt order) on the lawfulness of Trump-administration impoundment or conditional restriction of PEPFAR-appropriated funds within 180 days.8neutral0.0No court ruling entered evidence stream
The Penobscot County, Maine HIV outbreak (40 confirmed cases Mar 20 2026, still growing Apr 7) will be officially recognized as a CDC HIV molecular cluster with ≥75 confirmed cases reported by Maine DHHS or CDC within 90 days.6neutral0.0No Maine DHHS or CDC update; connector drought
At least one published case of incident (breakthrough) HIV-1 infection in an individual receiving twice-yearly lenacapavir PrEP per protocol, with documented capsid-gene resistance-associated mutation (Q67H/K, N74D, M66I, K70N, T107N/A, or similar), will be reported within 180 days of LEN PrEP rollout expansion (post-FDA approval Jun 2025, PEPFAR+GF investment Apr 2026).4neutral0.0No LEN breakthrough case report published

Coverage

No coverage table published.